Intriguingly, the abrogation of GPR146 functionality is not correlated with elevations in hepatic enzymes, often employed as diagnostic indices for hepatic steatosis or non-alcoholic fatty liver disease. This evidence concerns the gene GPR146 and metabolic dysfunction-associated steatotic liver disease.